Fifth Third Bancorp increased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 18.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 77,761 shares of the exchange traded fund’s stock after purchasing an additional 12,160 shares during the quarter. Fifth Third Bancorp owned approximately 0.12% of SPDR S&P Biotech ETF worth $9,932,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Financial Life Planners purchased a new stake in SPDR S&P Biotech ETF in the 1st quarter worth approximately $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $27,000. Intesa Sanpaolo Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $30,000. SHP Wealth Management acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth $31,000. Finally, Legacy Wealth Managment LLC ID purchased a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $32,000.
SPDR S&P Biotech ETF Trading Up 0.5%
Shares of NYSEARCA:XBI opened at $156.22 on Thursday. The firm has a market cap of $10.63 billion, a price-to-earnings ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a 1 year low of $84.39 and a 1 year high of $165.71. The business has a fifty day simple moving average of $141.70 and a 200 day simple moving average of $132.04.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Why Johnson & Johnson’s Earnings Dip Looks Like a Buying Opportunity
- CPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive Stocks
- Why ASML’s AI Monopoly Is Still Getting Stronger
- Apple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before Earnings
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
